Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Joseph Benesch
Joseph Benesch is recorded as CFO at Fortress Biotech, Inc. (FBIO) and CFO at Journey Medical Corp (DERM). Journey Medical Corp reported in an 8-K filed May 1, 2024 that Joseph Benesch was appointed Chief Financial Officer, effective April 26, 2024. Journey Medical Corp reported in an 8-K filed January 20, 2023 that Joseph Benesch was appointed interim Chief Financial Officer, effective January 27, 2023. The proxy statement of Journey Medical Corp reports total compensation of $823,673 for Joseph Benesch in fiscal 2025, including a base salary of $318,270. Disclosed compensation is on record for 3 fiscal years. Joseph Benesch has spoken on 10 earnings calls across 1 company, most recently for Journey Medical Corp on May 13, 2026.
“On April 26, 2024, the Board of Directors (the "Board") of Journey Medical Corporation (the "Company") appointed Joseph Benesch, age 57, as the Company's permanent Chief Financial Officer.”
Journey Medical Corp Form 8-K, filed May 1, 2024
· Read the filing
“Joseph Benesch, age 56, the Company's Corporate Controller, was appointed as the Company's interim Chief Financial Officer, effective January 27, 2023.”
Journey Medical Corp Form 8-K, filed January 20, 2023
· Read the filing
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
